NCT04612556View on ClinicalTrials.gov

Efficacy of Mepolizumab in Severe Asthmatics on a Long Term (MESILICO)

Active, not recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2025

Conditions
Asthma; EosinophilicSevere AsthmaLate-Onset Asthma
Interventions
DRUG

Mepolizumab 100 MG [Nucala]

subcutaneous injection once a month

Trial Locations (1)

57010

Pulmonary Clinic of Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki

All Listed Sponsors
collaborator

NHS Pulmonary Clinic G. Papanikolaou Hospital, Thessaloniki, Greece

UNKNOWN

collaborator

Pulmonary Clinic of Army Hospital Thessaloniki Greece

UNKNOWN

collaborator

Pulmonary Clinic, Democritus University of Thrace

UNKNOWN

collaborator

Pulmonary Clinic, University of Ioannina

UNKNOWN

collaborator

1st Pulmonary Clinic, Kapodistrian University of Athens

UNKNOWN

collaborator

2nd Pulmonary Clinic, Kapodistrian University of Athens

UNKNOWN

collaborator

NHS 7th Pulmonary Clinic, Sotiria Hospital, Athens

UNKNOWN

lead

Aristotle University Of Thessaloniki

OTHER